Clinical Trial Update: RIPE vs RIPE Plus N-acetylcysteine in Patients With HIV/TB Co-infection [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial compares the RIPE tuberculosis regimen alone versus RIPE with added N-acetylcysteine in patients co-infected with HIV and tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Pulmonary Tuberculosis

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)
• RIPE regimen (Rifampin/Isoniazid/Pyrazinamide/Ethambutol) (Rifampin; Isoniazid; Pyrazinamide; Ethambutol (RIPE) combination)

Snippet

Sponsor: Fundação de Medicina Tropical Dr. Heitor Vieira Dourado | Conditions: Tuberculosis, Pulmonary, HIV/AIDS | Phase 2 | Status: UNKNOWN